Ontology highlight
ABSTRACT:
SUBMITTER: Kayki-Mutlu G
PROVIDER: S-EPMC10034907 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature
Kayki-Mutlu Gizem G Aksoyalp Zinnet Sevval ZS Wojnowski Leszek L Michel Martin C MC
Naunyn-Schmiedeberg's archives of pharmacology 20230323 8
While new drug approvals by the U.S. Food and Drug Administration (FDA) had remained stable or even increased in the first 2 years of the COVID-19 pandemic, the 37 newly approved drugs in 2022 are considerably less than the 53 and 50 new drugs approved in 2020 and 2021, respectively, and less than the rolling 10-year average of 43. As in previous years of this annual review, we assign these new drugs to one of three levels of innovation: first drug against a condition ("first-in-indication"), fi ...[more]